Quality Metrics that Matter with Kimberly Wallbank episode artwork

EPISODE · Aug 19, 2024 · 41 MIN

Quality Metrics that Matter with Kimberly Wallbank

from The Life Science Rundown · host The FDA Group

The FDA Group's Nick Capman sits down with quality management consultant Kimberly Wallbank to discuss the challenges and best practices of implementing effective quality metrics in the life sciences industry. Discussion points include: Quality vs. Quantity in Metrics: Kimberly emphasizes the importance of focusing on meaningful metrics rather than simply tracking throughput. Aligning Metrics with Business Goals: Kimberly discusses how to connect quality metrics to financial impacts and overall business objectives. Optimal Number of Metrics: Kimberly advises on starting with a few key metrics and gradually expanding, while regularly reassessing their relevance. Frequency of Metric Reviews: Kimberly recommends monthly reviews at minimum, with the possibility of more frequent checks for critical metrics. Balancing Value and Effort in Data Collection: Kimberly explains the importance of weighing the potential insights against the resources required to collect and analyze data. Essential Quality Metrics: Kimberly outlines key categories of metrics that should always be included in a quality scorecard. Adding and Removing Metrics: Kimberly provides guidance on how to determine when to update the metrics on a scorecard. Common Implementation Challenges: Kimberly addresses issues such as stakeholder understanding, data structure, and involving the right people in metric discussions. Continuous Improvement: Kimberly stresses the importance of viewing the quality scorecard as a living document that evolves with the business. Practical Application: Kimberly shares real-world examples from her experience to illustrate effective metric implementation and use. — The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. For project or resource needs, visit ⁠thefdagroup.com⁠.

The FDA Group's Nick Capman sits down with quality management consultant Kimberly Wallbank to discuss the challenges and best practices of implementing effective quality metrics in the life sciences industry. Discussion points include: Quality vs. Quantity in Metrics: Kimberly emphasizes the importance of focusing on meaningful metrics rather than simply tracking throughput. Aligning Metrics with Business Goals: Kimberly discusses how to connect quality metrics to financial impacts and overall business objectives. Optimal Number of Metrics: Kimberly advises on starting with a few key metrics and gradually expanding, while regularly reassessing their relevance. Frequency of Metric Reviews: Kimberly recommends monthly reviews at minimum, with the possibility of more frequent checks for critical metrics. Balancing Value and Effort in Data Collection: Kimberly explains the importance of weighing the potential insights against the resources required to collect and analyze data. Essential Quality Metrics: Kimberly outlines key categories of metrics that should always be included in a quality scorecard. Adding and Removing Metrics: Kimberly provides guidance on how to determine when to update the metrics on a scorecard. Common Implementation Challenges: Kimberly addresses issues such as stakeholder understanding, data structure, and involving the right people in metric discussions. Continuous Improvement: Kimberly stresses the importance of viewing the quality scorecard as a living document that evolves with the business. Practical Application: Kimberly shares real-world examples from her experience to illustrate effective metric implementation and use. — The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. For project or resource needs, visit ⁠thefdagroup.com⁠.

NOW PLAYING

Quality Metrics that Matter with Kimberly Wallbank

0:00 41:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Life Science Rundown?

This episode is 41 minutes long.

When was this The Life Science Rundown episode published?

This episode was published on August 19, 2024.

What is this episode about?

The FDA Group's Nick Capman sits down with quality management consultant Kimberly Wallbank to discuss the challenges and best practices of implementing effective quality metrics in the life sciences industry. Discussion points include: Quality vs....

Can I download this The Life Science Rundown episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!